UA98676C2 - Zibotentan composition containing mannitol and/or microcrystalline cellulose - Google Patents

Zibotentan composition containing mannitol and/or microcrystalline cellulose

Info

Publication number
UA98676C2
UA98676C2 UAA201005506A UAA201005506A UA98676C2 UA 98676 C2 UA98676 C2 UA 98676C2 UA A201005506 A UAA201005506 A UA A201005506A UA A201005506 A UAA201005506 A UA A201005506A UA 98676 C2 UA98676 C2 UA 98676C2
Authority
UA
Ukraine
Prior art keywords
microcrystalline cellulose
zibotentan
composition containing
containing mannitol
mannitol
Prior art date
Application number
UAA201005506A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Джон Девид Блай
Эндрю Джон Дей
Киран Джеймс Леннон
Original Assignee
Астразенека Аб
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Астразенека Аб filed Critical Астразенека Аб
Publication of UA98676C2 publication Critical patent/UA98676C2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A pharmaceutical composition which comprises N-(3-methoxy-5-methylpyrazin-2-yl)-2-(4-[l,3,4-oxadiazol-2-yl]phenyl)pyridine-3-sulphonamidewithmanmtol and/or microcrystalline cellulose is described.
UAA201005506A 2007-10-12 2008-10-09 Zibotentan composition containing mannitol and/or microcrystalline cellulose UA98676C2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US97973607P 2007-10-12 2007-10-12

Publications (1)

Publication Number Publication Date
UA98676C2 true UA98676C2 (en) 2012-06-11

Family

ID=50847025

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201005506A UA98676C2 (en) 2007-10-12 2008-10-09 Zibotentan composition containing mannitol and/or microcrystalline cellulose

Country Status (1)

Country Link
UA (1) UA98676C2 (en)

Similar Documents

Publication Publication Date Title
MX2010003989A (en) Composition 064.
MX2009003038A (en) 5-substituted quinazolinone derivatives and compositions comprising and methods of using the same.
CL2007002930A1 (en) A COMPOUND 4- [4 - ({[4-CHLORINE-3- (TRIFLUOROMETIL) PHENYL] CARBAMOIL} AMINO) -3-FLUOROFENOXI] -N-METHYLPIRIDIN-2-CARBONXAMIDE MONOHIDRATADO; PREPARATION PROCESS; COMPOSITION AND PHARMACEUTICAL COMBINATION; AND USE FOR THE TREATMENT OF HYPERPROLIFERATI DISORDERS
CL2011002697A1 (en) Compounds derived from 3- [4- (oxo-dihydropyridin) benzyl] -1,3-oxazin-one hydrated, 11beta-hsd1 inhibitors; pharmaceutical composition comprising them; and its use in the treatment of diabetes
RS50624B (en) Monohydrochloride salt of 1- [3- [3- (4-chlorophenyl) propoxy] propyl] -piperidine
DK1954684T3 (en) Oxazole compound and pharmaceutical composition.
ATE442349T1 (en) DIACYLGLYCEROL ACYLTRANSFERASE INHIBITORS
MY150647A (en) 1-[2-(2,4-dimethylphenylsulfanyl)-phenyl] piperazine as a compound with combined serotonin reuptake, 5-ht3 and 5-ht1a activity for the treatment of cognitive impairment
TW200716628A (en) Novel compounds
WO2009001060A3 (en) Use of compounds for preparing anti-tuberculosis agents
AU2006336504A8 (en) 1-(benzo [D] [1,3] dioxol-5-yl) -N- (phenyl) cyclopropane- carboxamide derivatives and related compounds as modulators of ATP-Binding Cassette transporters for the treatment of Cystic Fibrosis
WO2007112014A3 (en) New therapeutic combinations for the treatment of depression
IS7766A (en) N- (3-methoxy-5-methylpyrazin-2-yl) -2- (4- [1,3,4-oxadiazol-2-yl] phenyl) pyridine-3-sulfonamide as an anticancer drug
CL2007000918A1 (en) COMPOUNDS DERIVED FROM ENFUMAFUNGINA, INHIBITORS OF (1,3) -BETA-D-GLUCANOSINTETASE; PHARMACEUTICAL COMPOSITION; AND USE TO TREAT A FUNGICAL INFECTION.
CL2011003138A1 (en) N- (protected- n- (3-methoxy-5-methylpyrazon-2-yl) -2- (4- [1,3,4-oxadiazol-2-yl] phenyl) pyridine-3-sulfonamide and its process of preparation.
IL179346A0 (en) 3-(4-(2-dihydroisoxazol-3-ylpyridin-5-yl)phenyl)-5-triazol-1-ylmethyloxazolidin-2-one derivatives as mao inhibitors for the treatment of bacterial infections
WO2007068728A3 (en) N-substituted pyrrolopyridinones active as kinase inhibitors
PE20060353A1 (en) ANTITUBERCULOSA PHARMACEUTICAL COMBINATION, INCLUDING N- (3 - [[4- (3-TRIFLUOROMETILPHENIL) PIPERAZINIL] METHYL] -2-METHYL-5-PHENYL-PYRROLYL) -4-PYRIDYLCARBOXAMIDE
CY1110942T1 (en) N- (3-Methoxy-ethoxy-5-methylpyrazin-2-yl) -2- (4- [1,3,4-oxadiazol-2-yl] phenyl) PYRIDINO-3-SULFINE SALT
MX2010005795A (en) Therapeutic uses of compounds having affinity to the serotonin transporter, serotonin receptors and noradrenalin transporter.
UA92592C2 (en) Combination comprising n-(3-methoxy-5-methylpyrazin-2-yl)-2-(4-[1,3,4-oxadiazol-2-yl]phenyl)pyridine-3-sulphonamide and an anti-mitotic cytotoxic agent such as taxane for the treatment of cancer
UA98676C2 (en) Zibotentan composition containing mannitol and/or microcrystalline cellulose
WO2006122012A3 (en) Polymorphic forms of (s)- tetrahydrofuran-3-yl-3-(3-(3-methoxy-4-(oxazol-5-yl) phenyl) ureido) benzylcarbamate
DK1906926T3 (en) Pharmaceutical composition comprising 2,3-dihydro-6-nitroimidazo [2,1-b] oxazole derivatives
EA200901387A1 (en) PHARMACEUTICAL COMPOSITION INCLUDING DESLORATADINE